Insights

Strategic Partnerships Debut has recently entered into partnerships with industry giants such as L'Oreal Group, demonstrating a willingness to collaborate and innovate in biotech beauty. Leveraging these partnerships can open doors for cross-selling opportunities and access to new markets.

Funding and Expansion With recent financial injections of $40 million in Series B funding, Debut is poised for expansion. Sales professionals can capitalize on the company's growth trajectory by offering complementary products or services to support their scaling operations.

Innovative Biotech Solutions Debut's focus on creating bio-based, clinically-proven products presents a unique selling point for sales representatives. Highlighting the superior quality, sustainability, and performance of Debut's offerings can appeal to conscious consumers seeking innovative beauty solutions.

Market Presence Debut's presence in notable publications and collaborations with key players in the beauty industry, such as L'Oreal and Kustom Group, enhances its market credibility. Sales professionals can leverage this reputation to build trust with potential clients and drive more sales.

Investment in Facilities Debut's investments in onshoring foreign production and constructing a bioindustrial manufacturing production facility indicate a focus on enhancing production capabilities. Sales teams can explore opportunities to provide equipment or services that support Debut's facility expansions for mutually beneficial partnerships.

Debut Tech Stack

Debut uses 8 technology products and services including Jupyter, Google Cloud, Retargeting, and more. Explore Debut's tech stack below.

  • Jupyter
    File Sharing
  • Google Cloud
    Infrastructure As A Service
  • Retargeting
    Marketing Automation
  • HubSpot
    Marketing Automation
  • Microsoft
    Miscellaneous
  • Microsoft Azure
    Platform As A Service
  • Lua
    Programming Languages
  • Greenhouse
    Recruitment Marketing

Media & News

Debut's Email Address Formats

Debut uses at least 1 format(s):
Debut Email FormatsExamplePercentage
First@debutbiotech.comJohn@debutbiotech.com
75%
FLast@debutbiotech.comJDoe@debutbiotech.com
20%
Last@debutbiotech.comDoe@debutbiotech.com
4%
First.Last@debutbiotech.comJohn.Doe@debutbiotech.com
1%

Frequently Asked Questions

Where is Debut's headquarters located?

Minus sign iconPlus sign icon
Debut's main headquarters is located at 11545 Sorrento Valley Rd Suite 310 San Diego, California 92121-3220 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is Debut's stock symbol?

Minus sign iconPlus sign icon
Debut is a publicly traded company; the company's stock symbol is DBTB.

What is Debut's official website and social media links?

Minus sign iconPlus sign icon
Debut's official website is debutbiotech.com and has social profiles on LinkedIn.

How much revenue does Debut generate?

Minus sign iconPlus sign icon
As of October 2024, Debut's annual revenue reached $15M.

What is Debut's SIC code NAICS code?

Minus sign iconPlus sign icon
Debut's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Debut have currently?

Minus sign iconPlus sign icon
As of October 2024, Debut has approximately 116 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Executive Officer: J. B.Chief Scientific Officer: M. W.Head Of Marketing & Communications: L. Z.. Explore Debut's employee directory with LeadIQ.

What industry does Debut belong to?

Minus sign iconPlus sign icon
Debut operates in the Biotechnology Research industry.

What technology does Debut use?

Minus sign iconPlus sign icon
Debut's tech stack includes JupyterGoogle CloudRetargetingHubSpotMicrosoftMicrosoft AzureLuaGreenhouse.

What is Debut's email format?

Minus sign iconPlus sign icon
Debut's email format typically follows the pattern of . Find more Debut email formats with LeadIQ.

How much funding has Debut raised to date?

Minus sign iconPlus sign icon
As of October 2024, Debut has raised $40M in funding. The last funding round occurred on Jun 02, 2023 for $40M.

When was Debut founded?

Minus sign iconPlus sign icon
Debut was founded in 2019.
Debut

Debut

Biotechnology ResearchCalifornia, United States51-200 Employees

Debut is pioneering the beauty industry’s shift from traditionally sourced ingredients derived from petroleum and cultivation to high-performing and inherently sustainable biotech ingredients. As a fully vertically-integrated global company, Debut creates superior, scientifically-engineered, bio-based and clinically-proven products and brands at scale to benefit people and planet. Our mission is to create a new beauty standard based on potency, purity, and performance.

Section iconCompany Overview

Headquarters
11545 Sorrento Valley Rd Suite 310 San Diego, California 92121-3220 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
DBTB
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $40M

    Debut has raised a total of $40M of funding over 4 rounds. Their latest funding round was raised on Jun 02, 2023 in the amount of $40M.

  • $10M$50M

    Debut's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $40M

    Debut has raised a total of $40M of funding over 4 rounds. Their latest funding round was raised on Jun 02, 2023 in the amount of $40M.

  • $10M$50M

    Debut's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.